Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-715-4 | CAS number: 1354569-12-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP in chemico study, ECVAM recommends use as weight of evidence only.
- Qualifier:
- according to guideline
- Guideline:
- other: Test method evaluated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM, November 2013).
- Principles of method if other than guideline:
- The reactivity of the test item was evaluated in chemico by monitoring peptide depletion following a 24-hour contact between the test item and synthetic cysteine and lysine peptides in the DPRA Assay. The result was applied for skin sensitization assessment.
- GLP compliance:
- no
- Remarks:
- The laboratory had CLP certificate. SOPs of the laboratory were followed.
- Type of study:
- other: Direct Peptide Reactivity Assay (DPRA)
- Species:
- other: none
- Strain:
- other: none
- Details on test animals and environmental conditions:
- A diluted solution of cysteine or lysine was incubated with the test item at the ratios 1:10 cysteine: test item and 1:50 lysine: test item for 24 hours.
Each chemical (test item or positive control) was pre-weighed and stored under appropriate conditions until ready to perform testing.
The positive control was dissolved in acetonitrile at 100 mM. The test item was dissolved in the selected vehicle (acetonitrile) at 100 mM. This formulation was a colorless liquid. Each formulation was prepared within 1 hour before use.
The synthetic cysteine peptide solution was prepared in an aqueous phosphate buffer (pH 7.5) solution. The detailed preparation method is described in a CiToxLAB France analytical method, specific to the DPRA test.
The lysine peptide solution was prepared in an aqueous ammonium acetate buffer (pH 10.2) solution. Thepreparation method is described in a CiToxLAB France analytical method, specific to the DPRA test. - Details on study design:
- All samples (co-elution control, QC, test item and positive control samples) were incubated during 24 (± 2) hours at room temperature and protected from light before injection onto the HPLC/UV system.
At the end of the incubation period, a visual inspection of the samples was performed prior to HPLC analysis. No precipitate was observed in the vials incubated with the cysteine peptide, as a result, these vials were directly transferred onto the HPLC/UV system. However, some "micelles" were observed in the vials incubated with the lysine peptide. Therefore these vials and QC sample vials as well, were centrifuged at 400 g for 5 minutes at room temperature. Supernatants were then collected and were transferred onto the HPLC/UV system. - Positive control substance(s):
- yes
- Remarks:
- cinnamaldehyde, CAS 14731-10-9
- Positive control results:
- After the analysis of the co-elution sample chromatograms, the test item was found to not co-elute either with the lysine or the cysteine peptides.
Mean percentage depletion values were calculated for each peptide using the formula described above. - Parameter:
- other: Migrated information from in vitro study
- Remarks on result:
- other: Reading: other: Mean depletion value citraconate 0.24 %. . Hours after challenge: 24.0. Group: other: lysine peptide. Dose level: 1:50 lysine:test item in acetonitrile. Total no. in groups: 3.0. Clinical observations: SD 0.2, % CV -70.6.
- Parameter:
- other: Migrated information from in vitro study
- Remarks on result:
- other: Reading: other: Mean depletion value citraconate 4.22 %. . Hours after challenge: 24.0. Group: other: cysteine peptide. Dose level: 1:10 cysteine:test item in acetonitrile. Total no. in groups: 3.0. Clinical observations: SD 0.58, % CV 13.28.
- Parameter:
- other: Migrated information from in vitro study
- Remarks on result:
- other: Reading: other: Mean depletion rate citraconate 1,99 %. . Hours after challenge: 24.0. Group: other: Mean of lysine and cysteine scores.
- Parameter:
- other: Migrated information from in vitro study
- Remarks on result:
- other: Reading: other: Mean depletion value control (cinnamanaldehyde) 65.54 %. . Hours after challenge: 24.0. Group: other: lysine peptide. Dose level: 100 mM in acetonitrile. Total no. in groups: 3.0. Clinical observations: SD 0.8, % CV 1.3.
- Parameter:
- other: Migrated information from in vitro study
- Remarks on result:
- other: Reading: other: Mean depletion value control (cinnamanaldehyde) 100 %. . Hours after challenge: 24.0. Group: other: cysteine. Dose level: 100 mM in acetonitrile. Total no. in groups: 3.0. Clinical observations: SD 0, % CV 0.
- Parameter:
- other: Migrated information from in vitro study
- Remarks on result:
- other: Reading: other: Mean depletion rate control (cinnamanaldehyde) 81.27 %. . Hours after challenge: 24.0. Group: other: Mean. Dose level: 100 mM in acetonitrile.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: other: ECVAM recommendation 2013
- Conclusions:
- The mean depletion values were: -0.24% for the lysine peptide, 4.22% for the cysteine peptide. The mean of the percentage cysteine and lysine depletions was calculated to be 1.99%. Compared to the method criterion 6.38 %, the test item was assessed to have no/minimal peptide reactivity.
- Executive summary:
The reactivity of bis (2 -ethylhexyl)citraconate was evaluated in chemico in a DPRA Assay (EURL ECVAM 2013) by monitoring peptide depletion following a 24-hour contact between the test item and synthetic cysteine and lysine peptides. The result was applied for skin sensitization assessment. The mean depletion values were -0.24% for the lysine peptide and 4.22% for the cysteine peptide. The mean of the percentage cysteine and lysine depletions was calculated to be 1.99%. Compared to the method criterion 6.38 %, the test item was assessed to have no/minimal peptide reactivity, suggesting no/minimal potential to cause skin sensitization.
The result is used as weight-of-evidence for classification and labelling of the substance (Klimisch 2), in line with the ECVAM recommendation.
Reference
Original result tables for the test item and for the positive control (including the calibration data and quality controls) are presented in Attachment 2.
The mean depletion values were: -0.24% for the lysine peptide, 4.22% for the cysteine peptide.
The mean of the percentage cysteine and percentage lysine depletions was calculated to be 1.99%.
Accordingly, the test item was considered to have no/minimal peptide reactivity (< 6.38 % criterion).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The reactivity of bis (2 -ethylhexyl)citraconate was evaluated in chemico in a DPRA Assay by monitoring peptide depletion following a 24-hour contact between the test item and synthetic cysteine and lysine peptides. The result was applied for skin sensitization assessment. The acceptance criteria of the samples for the calibration curve, quality control and positive control were satisfied. The study was therefore considered to be valid (Klimisch 2), and applied as weight of evidence for classification and labelling. The mean depletion values were -0.24% for the lysine peptide and 4.22% for the cysteine peptide. The mean of the percentage cysteine and percentage lysine depletions was calculated to be 1.99%. The test item was assessed to have no/minimal peptide reactivity, suggesting no/minimal potential to cause skin sensitization.
The TOPKAT 4.5 QSAR model indicates that bis-(2-ethylhexyl)citraconate is in the category of non-sensitizers. An external expert assessment considered the evidence as conclusive. The statistics in the model meets the 5 OECD principles for QSAR models validation. The four principles set by the REACH Annex XI (1.3) are also met. The results are therefore rated as reliable (Klimisch 2), and applied as weight of evidence for classification and labelling.
The DEREK modelling of bis(2 -ethylhexyl)citraconate for skin irritation was rated as plausible, based on substructural features of the molecule. The expert assessment concludes that the skin sensitisation alert was found in 3 databases with 20 structures, where approximately 50% were sensitisers and 50% non-sensitisers, so the reliability of this alert is not high.The reliability is therefore ranked as Klimisch 4 (not assignable).
Conclusion:
As weight of evidence from DPRA study and TOPKAT assessment there is a low likelihood that bis-(2-ethylhexyl)citraconate may be a skin sensitizer.
Migrated from Short description of key information:
The skin sensitisation was assessed with i) an in vitro DPRA Assay suggesting no/minimal skin sensitisation potential, ii) DEREK QSAR modelling as plausible and iii) TOPKAT QSAR modelling as a non-sensitizer.
Justification for selection of skin sensitisation endpoint:
Weight of evidence: an in vitro DPRA study supported by TOPKAT and DEREK models. Two studies are rated as Klimisch 2, and third as Klimisch 4.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
- Migrated from Short description of key information:
In accordance with REACH Article 18, testing is not required for this type of submission.
Justification for classification or non-classification
The available data from an in vitro test and a QSAR model do not meet the skin sensitizer classification criteria of the CLP regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.